FDA approval of clinical trial expansion of Prima System US feasibility study to Stanford Medicine

Pixium Vision announces the approval by US FDA of the expansion of the Prima System* US feasibility study to include Stanford Medicine as a clinical site.

This third location for the study at the Byers Eye Institute at Stanford Medicine joins the original two locations at the UPMC Eye Center in Pittsburgh and the Bascom Palmer Eye Institute in Miami.

The US feasibility study aims to evaluate the safety and performance of the Prima System in patients with dry AMD and will recruit 5 patients. The primary endpoint is Near Visual Acuity assessment measured at 12 months. Data readout is expected in 2023. A separate feasibility study conducted in France showed improved visual acuity in patients with dry AMD with use of the Prima System. A pivotal study of the Prima System is underway in several European countries.

Pixium licensed technology from Stanford University.

 “We are very pleased to be expanding the number of sites of our Prima System US feasibility study,” said Lloyd Diamond, Chief Executive Officer of Pixium Vision. “We know that the medical team is very familiar with the design of the implants and we look forward to observing the results of their procedures first hand.”

* CAUTION – Investigational device. Limited by United States law to investigational use.

2022-03-29T18:17:30+02:00March 29th, 2022|News, Press Releases|

Pixium Vision to participate in the 2022 Virtual Growth Conference

Pixium Vision announces that Lloyd Diamond, Chief Executive Officer of Pixium Vision, has been invited to present at the 2022 Virtual Growth Conference, presented by Maxim Group LLC and hosted by M-Vest from March 28 to 30, 9.00 am to 5.00 pm EDT / 3.00 pm to 11.00 pm CET.

Sign up here to access the presentation.

During this virtual conference, investors will hear from executives from a wide range of sectors including Biotech, Clean Energy, Electric Vehicles, Financial Services, Fintech & REITS, Gaming & Entertainment, Healthcare, Healthcare IT, Infrastructure, Shipping and Technology/Media/Telecom. The conference will feature company presentations, fireside chats, roundtable discussions, and live Q&A with CEOs moderated by Maxim Research Analysts.

This conference will be live on M-Vest. To attend, just sign up to become an M-Vest member.

Click here to reserve your seat.

2022-03-24T17:38:29+01:00March 24th, 2022|Events, News, Press Releases|

LSI USA ’22 – Emerging Medtech Summit

Lloyd Diamond is presenting on Thursday 17 March at the LSI event at 10:15am PT, Monarch Ball Room

Lloyd Diamond, CEO at Pixium Vision, sits down with Benjamin Glenn of A Matter of Innovation at #LSI2021 Life Science Intelligence to discuss his company Pixium Vision’s amazing new retinal implant, developed in conjunction with Stanford- giving patients who are legally blind the gift of sight, (the technology offers those suffering from the dry form of age related macular degeneration the ability to regain their detailed central vision), allowing them to once again cook, take the right medications at the right time, pass vision tests they had failed in the past, and to see their grandchildren’s faces again; the value of offering this technology to elderly patients, how age is a mental state, not a number; the supportive ecosystem of the Passage de L’Innovation in Paris, and how Medtech investments function in France.

2022-03-14T13:29:48+01:00March 14th, 2022|Events, News|
Go to Top